Want to see GYRE full AI Analyst Report?
Gyre Therapeutics (GYRE) Ownership Overview
63.46% Insiders
1.46% Mutual Funds
<0.01% Other Institutional Investors
1.71% ETFs
33.37% Public Companies and
Individual Investors
The ownership structure of Gyre Therapeutics (GYRE) stock is a mix of institutional, retail, and individual investors. Approximately 3.17% of the company’s stock is owned by Institutional Investors, 63.46% is owned by Insiders, and 33.37% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 22, 2026 | xxxxxxxxxxxxx | $68700 | |
Jun 15, 2026 | xxxxxxxxxxxxx | $17276 | |
Jun 11, 2026 | xxxxxxxxxxxxx | $128886 | |
Jun 08, 2026 | xxxxxxxxxxxxx | $218561 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 64,005,887 | Insider | 60.36% | 470,443,269 | |
| 2,565,226 | Insider | 2.42% | 18,854,411 | |
| 978,914 | Institution | 0.92% | 7,195,018 | |
| 960,624 | Institution | 0.91% | 7,060,586 | |
| 700,000 | Insider | 0.66% | 5,145,000 | |
| 543,301 | Institution | 0.51% | 3,993,262 | |
| 241,649 | Institution | 0.23% | 1,776,120 | |
| 202,559 | Institution | 0.19% | 1,488,809 | |
| 124,769 | Institution | 0.12% | 917,052 | |
| 69,974 | Institution | 0.07% | 514,309 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 960,624 | Institution | 0.91% | 7,060,586 | |
| 241,649 | Institution | 0.23% | 1,776,120 | |
| 124,769 | Institution | 0.12% | 917,052 | |
| 69,974 | Institution | 0.07% | 514,309 | |
| 45,574 | Institution | 0.04% | 334,969 | |
| 23,132 | Institution | 0.02% | 170,020 | |
| 19,723 | Institution | 0.02% | 144,964 | |
| 12,676 | Institution | 0.01% | 93,169 | |
| 10,904 | Institution | 0.01% | 80,144 | |
| 8,491 | Institution | <0.01% | 62,409 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 614,654 | Institution | 0.58% | 4,038,277 | |
| 399,868 | Institution | 0.38% | 2,939,030 | |
| 238,693 | Institution | 0.23% | 1,568,213 | |
| 184,559 | Institution | 0.17% | 1,312,214 | |
| 105,759 | Institution | 0.10% | 694,837 | |
| 100,851 | Institution | 0.10% | 741,255 | |
| 41,538 | Institution | 0.04% | 305,304 | |
| 19,253 | Institution | 0.02% | 141,510 | |
| 18,000 | Institution | 0.02% | 127,980 | |
| 13,896 | Institution | 0.01% | 101,858 |
FAQ
Who Owns Gyre Therapeutics (GYRE)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 63.46% is held by insiders, and 33.37% is held by retail investors.
What percentage of Gyre Therapeutics (GYRE) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Gyre Therapeutics (GYRE) stock is held by institutional investors.
What percentage of Gyre Therapeutics (GYRE) stock is held by retail investors?
According to the latest TipRanks data, approximately 33.37% of Gyre Therapeutics (GYRE) stock is held by retail investors.
Who owns the most shares of Gyre Therapeutics (GYRE)?
GNI Group Ltd. owns the most shares of Gyre Therapeutics (GYRE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.